Stock listing
Solid Biosciences Inc.
Selected listing: SLDB · NASDAQ · USD · US
Solid Biosciences Inc. (NASDAQ:SLDB), Health Technology. Latest release Oct 1, 2026: Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- NASDAQ:SLDB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Solid Biosciences Inc.
Solid Biosciences Inc. is a public company traded on the American stock market under the ticker SLDB. Solid Biosciences focuses on advancing therapies for Duchenne muscular dystrophy and aims to improve the lives of patients affected by this condition.
Latest news from Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Solid Biosciences and NanoMosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics
June 2, 2026
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 12, 2026
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 7, 2026
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
April 30, 2026
Events
Replays
Solid Biosciences Inc. (SLDB) Q1 2022 Earnings Call
Wed, Apr 27, 2022 · 08:00 AM ET
Watch
Research Solid Biosciences Inc.
Solid Biosciences Inc. company profile
View the public company page for Solid Biosciences Inc. on 6ix.
Solid Biosciences Inc. news
Read company news and market updates connected to Solid Biosciences Inc..
Solid Biosciences Inc. investor events
Find investor webinars, events, and replay context for Solid Biosciences Inc..